Insights on NanoViricides Inc (OTCBB:NNVC) You Need to Know

Repost This

Las Vegas, NV -- (SBWIRE) -- 06/14/2013 -- NanoViricides Inc (OTCBB:NNVC) gained 1.52 percent and is currently trading at $0.67. The company share traded at highest of $0.80 and lowest of $0.32 during last 52 weeks.

NanoViricides filed an Orphan Drug application for DengueCide™. It is drug candidate for dengue fever treatment. The application is filed with Office of Orphan Product Development of FDA.

The company is consulting Cote´ Orphan Consulting to support orphan drug application. The consultation will help NNVC to determine how DengueCide™ drug candidate qualifies for orphan drug status application.

The company’s drug candidate is a nanoviricide® that presented high effectiveness in animal testing. The animals have shown 50% survival rate in tests.

NanoViricides, nano-biopharmaceutical firm. The company discovers, develops and commercializes therapeutics to treat life-threatening viral infections. NNVC offers many drugs in that are based on several patents. The company is offering and working on drugs for treatment of HIV, Asian Bird Flu Virus, Herpes Simplex Virus, Hepatitis C and B etc.

To find out what ChartPoppers projects for NanoViricides Inc for both short term and long term please click here: NNVC

ChartPoppers Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit ChartPoppers right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly ChartPoppers is the hottest thing in OTC picks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical., nor any of its affiliates are not registered investment advisors or broker dealers.